Powered by TradingView
ZYNE
Zynerba Pharmaceuticals, Inc.
Exchange: NASDAQ
Zynerba Pharmaceuticals develops synthetic cannabinoid based medicines to help treat a wide-range of needs. Currently, the company has a synthetic gel in phase 2 of clinical development for epilepsy.
Search for ZYNE news >>Do you represent Zynerba Pharmaceuticals, Inc.? Get in touch to claim your listing.
Contact Info:
-
Website:
-
Phone:
-
Headquarters:
80 West Lancaster Avenue Suite 300, Devon, PA United States
More Cannabis Stocks
Learn about other publicly-traded cannabis & hemp companies:
SLTK
Solis Tek Inc.
OTCMKTS
CANN
General Cannabis Corporation
OTCMKTS
CRBP
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ
ABBV
AbbVie Inc.
NYSE
MSRT
MassRoots, Inc.
OTCMKTS
CVSI
CV Sciences, Inc.
OTCMKTS